FR941202-0-00026 FR941202-0-00001 PART 35_MEDICAL USE OF BYPRODUCT MATERIAL 10. The authority citation for Part 35 continues to read as follows: Authority: Secs. 81, 161, 182, 183, 68 Stat. 935, 948, 953, 954, as amended (42 U.S.C. 2111, 2201, 2232, 2233); sec. 201, 88 Stat. 1242, as amended (42 U.S.C. 5841). 11. In §35.2, the definition of visiting authorized user is removed; the definitions of authorized nuclear pharmacist and pharmacist are added; and the definitions of authorized user, medical use, misadministration _paragraphs (1)(i), (2)(i), (3)(i), (4)(i), (4)(iii), (5)(i), (6)(i), and (6)(ii), recordable event _paragraph (5), and written directive _the introductory text, are revised to read as follows: §35.2 Definitions. * * * * * Authorized nuclear pharmacist means a pharmacist who is: (1) Board certified as a nuclear pharmacist by the Board of Pharmaceutical Specialties; (2) Identified as an authorized nuclear pharmacist on a Commission or Agreement State license that authorizes the use of byproduct material in the practice of nuclear pharmacy; or (3) Identified as an authorized nuclear pharmacist on a permit issued by a Commission or Agreement State specific licensee of broad scope that is authorized to permit the use of byproduct material in the practice of nuclear pharmacy. Authorized user means a physician, dentist, or podiatrist who is: (1) Board certified by at least one of the boards listed in Paragraph (a) of §§35.910, 35.920, 35.930, 35.940, 35.950, or 35.960; (2) Identified as an authorized user on a Commission or Agreement State license that authorizes the medical use of byproduct material; or (3) Identified as an authorized user on a permit issued by a Commission or Agreement State specific licensee of broad scope that is authorized to permit the medical use of byproduct material. * * * * * Medical use means the intentional internal or external administration of byproduct material or the radiation therefrom to patients or human research subjects under the supervision of an authorized user. * * * * * Misadministration means the administration of: (1) *␣*␣* (i) Involving the wrong patient or human research subject, or wrong radiopharmaceutical; or * * * * * (2) *␣*␣* (i) Involving the wrong patient or human research subject, wrong radiopharmaceutical, or wrong route of administration; or * * * * * (3) *␣*␣* (i) Involving the wrong patient or human research subject, or wrong treatment site; or * * * * * (4) *␣*␣* (i) Involving the wrong patient or human research subject, wrong mode of treatment, or wrong treatment site; * * * * * (iii) When the calculated weekly administered dose exceeds the weekly prescribed dose by 30 percent or more of the weekly prescribed dose; or * * * * * (5) *␣*␣* (i) Involving the wrong patient or human research subject, wrong radioisotope, or wrong treatment site (excluding, for permanent implants, seeds that were implanted in the correct site but migrated outside the treatment site); * * * * * (6) *␣*␣* (i) Involving the wrong patient or human research subject, wrong radiopharmaceutical, wrong route of administration, or when the administered dosage differs from the prescribed dosage; and (ii) When the dose to the patient or human research subject exceeds 5 rems effective dose equivalent or 50 rems dose equivalent to any individual organ. * * * * *
